Cryoport Inc (CYRX) 0.5010 $CYRX
Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal
PR Newswire - Tue Feb 10, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization ("IVF" market in Nepal.
CryoPort's (CYRX) CEO Jerrell Shelton on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:08PM CST
Cryoport EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 7:36AM CST
Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015
PR Newswire - Thu Feb 05, 7:30AM CST
Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.
Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th
PR Newswire - Thu Jan 29, 11:17AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company" , the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th.
Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand
PR Newswire - Mon Jan 26, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company" , the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States.
Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team
PR Newswire - Tue Jan 20, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ( "Company" , the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems.
Cryoport Appoints Richard J. Berman to its Board of Directors
PR Newswire - Mon Jan 12, 7:36AM CST
Cryoport, Inc. (OTC BB:CYRX) ("Company" , the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations, vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee.
Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs
PR Newswire - Mon Dec 29, 7:30AM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC ("TRL" . Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping.
Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015
PR Newswire - Wed Nov 12, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.
Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry
PR Newswire - Mon Nov 03, 1:27PM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry.
Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists
PR Newswire - Tue Oct 14, 7:00AM CDT
Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its "Regenerative Medicine Point-of-Care Repository Solution" for Liventa Bioscience's introduction of Liventa's AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.
Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe
PR Newswire Europe - Tue Sep 16, 7:03AM CDT
- New "state-of-the-art" operations center to provide convenient, comprehensive cryogenic logistics support for Cryoport's European client base
Cryoport names Curt Kole as VP, Strategic Business Development
M2 - Tue Sep 09, 4:30AM CDT
Logistics solutions company Cryoport (OTC BB:CYRX) disclosed on Monday that it has appointed Curt Kole as vice president of its Strategic Business Development.
Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force
PR Newswire - Mon Sep 08, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport's new business development personnel will support the Company's rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.
Cryoport to Present at the Aegis Healthcare & Technology Conference on September 12, 2014
PR Newswire - Tue Sep 02, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.
Cryoport reports rise in sales team to meet its increasing customer demand
M2 - Wed Aug 13, 7:07AM CDT
Cryogenic logistics company Cryoport (OTC BB:CYRX) Tuesday announced the launch of its sales force expansion programme to accelerate its rapidly expanding customer base.
Cryoport Expands Sales Force to Meet Increasing Demand
PR Newswire - Tue Aug 12, 7:30AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions, announced today the implementation of its sales force expansion program to accelerate the Company's rapidly expanding customer base. In addition to our key market sectors, the expanded sales team will provide direct support to our global integrator partners, who uniquely employ Cryoport's 'powered by Cryoport(TM)' solutions into their respective strategies for the life sciences cold chain.
Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015
PR Newswire - Thu Jul 31, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.
Cryoport Initiates Support of the Growing In-Vitro Fertilization Market in Nepal
PR Newswire - Tue Feb 10, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it has initiated support of the growing in-vitro fertilization ("IVF" market in Nepal. CryoPort's (CYRX) CEO Jerrell Shelton on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:08PM CST
Cryoport EPS of -$0.03
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 7:36AM CST
Cryoport Reports Record Results; Grows Revenue by 50% for the First Nine Months of Fiscal 2015
PR Newswire - Thu Feb 05, 7:30AM CST
Cryoport, Inc. (CYRX) today announced financial results for its fiscal third quarter and nine months ended December 31, 2014.
Cryoport to Report Financial Results for Fiscal Third Quarter of 2015 and Provide Business Update on Thursday, February 5th
PR Newswire - Thu Jan 29, 11:17AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced it will release its financial results for the fiscal third quarter ended December 31, 2014 on Thursday, February 5th. Cryoport Expands Sales Force To Address Growing Life Sciences Industry Demand
PR Newswire - Mon Jan 26, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, and reproductive medicine, today announced the expansion and restructuring of its national sales force in the United States. Cryoport Appoints Mark W. Sawicki as Chief Commercial Officer to Lead Sales and Marketing Team
PR Newswire - Tue Jan 20, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) ( "Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced the appointment of Mark W. Sawicki, Ph.D. as Chief Commercial Officer of Cryoport Systems. Cryoport Appoints Richard J. Berman to its Board of Directors
PR Newswire - Mon Jan 12, 7:36AM CST
Cryoport, Inc. (OTC BB:CYRX) ("Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences serving markets including immunotherapies, stem cells, cell lines, contract research organizations, vaccine manufacturers, and IVF, today announced the appointment of Richard J. Berman to its Board of Directors. Mr. Berman will also serve as Chairman of the Audit Committee and Compensation Committee. Cryoport Designated as Exclusive Cryogenic Logistics Provider to Triangle Research Labs
PR Newswire - Mon Dec 29, 7:30AM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions for life sciences, announced today that it has entered into an agreement with Triangle Research Labs, LLC ("TRL" . Under the agreement, Cryoport becomes the exclusive cryogenic logistics provider for TRL, providing it with the ability to support its overall demand growth and meet its ever-increasing demand for same day cryogenic shipping. Cryoport Increases Revenue by 65% for the First Six Months of Fiscal 2015
PR Newswire - Wed Nov 12, 7:30AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for its second quarter and six months ended September 30, 2014.
Cryoport & UPS Collaborate on Cryogenic Logistics Solutions for the Healthcare Industry
PR Newswire - Mon Nov 03, 1:27PM CST
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, announced today that it is collaborating with UPS to enhance its temperature-sensitive shipping offerings to the healthcare industry. Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists
PR Newswire - Tue Oct 14, 7:00AM CDT
Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its "Regenerative Medicine Point-of-Care Repository Solution" for Liventa Bioscience's introduction of Liventa's AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.
Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe
PR Newswire Europe - Tue Sep 16, 7:03AM CDT
- New "state-of-the-art" operations center to provide convenient, comprehensive cryogenic logistics support for Cryoport's European client base
Cryoport names Curt Kole as VP, Strategic Business Development
M2 - Tue Sep 09, 4:30AM CDT
Logistics solutions company Cryoport (OTC BB:CYRX) disclosed on Monday that it has appointed Curt Kole as vice president of its Strategic Business Development.
Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force
PR Newswire - Mon Sep 08, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport's new business development personnel will support the Company's rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company. Cryoport to Present at the Aegis Healthcare & Technology Conference on September 12, 2014
PR Newswire - Tue Sep 02, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas. Cryoport reports rise in sales team to meet its increasing customer demand
M2 - Wed Aug 13, 7:07AM CDT
Cryogenic logistics company Cryoport (OTC BB:CYRX) Tuesday announced the launch of its sales force expansion programme to accelerate its rapidly expanding customer base.
Cryoport Expands Sales Force to Meet Increasing Demand
PR Newswire - Tue Aug 12, 7:30AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, announced today the implementation of its sales force expansion program to accelerate the Company's rapidly expanding customer base. In addition to our key market sectors, the expanded sales team will provide direct support to our global integrator partners, who uniquely employ Cryoport's 'powered by Cryoport(TM)' solutions into their respective strategies for the life sciences cold chain. Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015
PR Newswire - Thu Jul 31, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.
